CommercialCoverageLow impact
Baroreflex Stimulation Devices (8.01.57)
Blue Shield of California·CA · Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Apr 1, 2026
We identified it
Nov 1, 2025
Summary
Blue Shield of California considers baroreflex stimulation devices investigational for heart failure and all other indications, meaning these procedures are not covered. The policy becomes effective April 1, 2026, giving practices advance notice that claims for these devices will be denied.
Action Required
By April 1, 2026: Billing team must update system to flag baroreflex stimulation device procedures as non-covered for Blue Shield of California members. Notify providers that these devices are considered investigational and claims will be denied. Update prior authorization lists to reflect investigational status.